Clincosm LogoSign in Get a demo

Extensive-stage Small-cell Lung Cancer

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Outcomes ofBrazilian Cohort of Previously Untreated Extensive

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Observational study
  • (no location specified)
Aug 24, 2023

Extensive Stage Small Cell Lung Cancer

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
    • Changsha, Hunan, China
      Hunan Cancer hospital
    Aug 6, 2023

    Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • (no location specified)
    May 22, 2023

    Extensive-stage Small-cell Lung Cancer Trial in Sydney, Brisbane, Melbourne (Radiotherapy, Chemotherapy)

    Recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Sydney, New South Wales, Australia
    • +6 more
    Mar 21, 2023

    Extensive-stage Small-cell Lung Cancer Trial in China (serplulimab, Cisplatin, Carboplatin)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Shantou, Guangdong, China
    • +6 more
    Mar 1, 2023

    Durvalumab in Combination With Standard Chemotherapy of

    Recruiting
    • Small-cell Lung Cancer
    • Extensive-stage Small-cell Lung Cancer
      • Néo Fáliro, Greece
        Metropolitan Hospital
      Mar 7, 2023

      Extensive-stage Small-cell Lung Cancer Trial in Japan, United States (DS-7300a)

      Recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Ifinatamab Deruxtecan (I-DXd)
      • Jacksonville, Florida
      • +22 more
      Jan 10, 2023

      Extensive-stage Small-cell Lung Cancer Trial (Surufatinib Durvalizumab EP/EC)

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Surufatinib Durvalizumab EP/EC
      • (no location specified)
      Dec 20, 2022

      Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Durvalumab 50 MG/1 ML Intravenous Solution
      • +4 more
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Oct 31, 2022

      Extensive-stage Small-cell Lung Cancer, Liver Metastases Trial in Los Angeles, Ann Arbor (Bevacizumab)

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Liver Metastases
      • Los Angeles, California
      • +2 more
      Oct 18, 2022

      Small Cell Lung Cancer, Platinum-Sensitive Lung Small Cell Carcinoma, Extensive-stage Small-cell Lung Cancer Trial in Bordeaux

      Not yet recruiting
      • Small Cell Lung Cancer
      • +2 more
      • Association of lurbinectedin and durvalumab
      • Association of carboplatin and etoposide
      • Bordeaux, France
        Institut Bergonié
      Oct 5, 2022

      Lung Cancer, Extensive-stage Small-cell Lung Cancer, Radiotherapy Trial (Durvalumab + carboplatin/cisplatin + etoposide,

      Not yet recruiting
      • Lung Cancer
      • +2 more
      • Durvalumab + carboplatin/cisplatin + etoposide
      • +2 more
      • (no location specified)
      Aug 3, 2022

      Safety of Zepzelca in Adult Extensive Stage Small Cell Lung

      Recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Huntsville, Alabama
      • +36 more
      Jul 25, 2022

      Extensive-stage Small-cell Lung Cancer Trial in Hangzhou (QL1706, Carboplatin, Etoposide)

      Recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Jul 13, 2022

      Extensive-stage Small-cell Lung Cancer Trial in Haikou (Trilaciclib)

      Active, not recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Haikou, Hainan, China
        Hainan General Hospital
      Jun 13, 2022

      Limited Stage Small Cell Lung Cancer, Extensive-stage Small-cell Lung Cancer Trial in Worldwide (Prophylactic cranial

      Not yet recruiting
      • Limited Stage Small Cell Lung Cancer
      • Extensive-stage Small-cell Lung Cancer
      • Prophylactic cranial irradiation
      • Graz, Austria
      • +37 more
      Jun 8, 2022

      Solid Tumor, Extensive-stage Small-cell Lung Cancer, Locally Advanced Breast Cancer Trial in Czechia, Poland (RP12146)

      Recruiting
      • Solid Tumor
      • +6 more
      • Hořovice, Czechia
      • +5 more
      Jun 8, 2022

      Lung Cancer, Extensive-stage Small-cell Lung Cancer, Durvalumab Trial in Chongqing, Zhengzhou, Chengdu (Low-dose radiotherapy,

      Recruiting
      • Lung Cancer
      • +2 more
      • Low-dose radiotherapy
      • +2 more
      • Chongqing, Chongqing, China
      • +2 more
      May 4, 2022

      Small-cell Lung Cancer, Extensive-stage Small-cell Lung Cancer, Lung Cancer Trial (Ablative Radiation, Durvalumab, Etoposide)

      Not yet recruiting
      • Small-cell Lung Cancer
      • +2 more
      • Ablative Radiation
      • +3 more
      • (no location specified)
      Mar 11, 2022

      Extensive-Stage Small-Cell Lung Cancer Trial in Shanghai (durvalumab + anlotinib, Durvalumab)

      Recruiting
      • Extensive-Stage Small-Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Chest Hospital
      Nov 1, 2021

      Prophylactic Cranial Irradiation in Extensive-stage Small Cell

      Recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Prophylactic Cranial Irradiation
      • Beijing, Beijing, China
        Cancer Insititute and Hosiptal of Chinese Academy of Medical Sci
      Sep 16, 2021

      Extensive-stage Small-cell Lung Cancer Trial in Shanghai (ZKAB001, Placebo, Carboplatin)

      Recruiting
      • Extensive-stage Small-cell Lung Cancer
      • ZKAB001
      • +3 more
      • Shanghai, Shanghai, China
        Shanghai Chest Hospital
      Sep 8, 2021

      Extensive-stage Small-cell Lung Cancer Trial in Changchun (Trilaciclib)

      Recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Changchun, China
        Jilin Cancer Hopspital
      Sep 5, 2021

      Extensive-stage Small-cell Lung Cancer Trial in Changsha (Platinum-etoposide+Anlotinib)

      Unknown status
      • Extensive-stage Small-cell Lung Cancer
      • Changsha, Hunan, China
        Xiangya Hospital Central South University
      Dec 17, 2020

      Extensive-Stage Small-Cell Lung Cancer Trial in Canada, Russian Federation, United States (Carfilzomib, Carboplatin, Etoposide)

      Completed
      Has Results
      • Extensive-Stage Small-Cell Lung Cancer
      • New Haven, Connecticut
      • +16 more
      Jul 26, 2017